PL383722A1 - Sposoby i materiały z trans-klomifenem do leczenia bezpłodności u mężczyzn - Google Patents
Sposoby i materiały z trans-klomifenem do leczenia bezpłodności u mężczyznInfo
- Publication number
- PL383722A1 PL383722A1 PL383722A PL38372206A PL383722A1 PL 383722 A1 PL383722 A1 PL 383722A1 PL 383722 A PL383722 A PL 383722A PL 38372206 A PL38372206 A PL 38372206A PL 383722 A1 PL383722 A1 PL 383722A1
- Authority
- PL
- Poland
- Prior art keywords
- clomiphen
- sterility
- men
- trans
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65001805P | 2005-02-04 | 2005-02-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
PL383722A1 true PL383722A1 (pl) | 2008-05-12 |
PL219509B1 PL219509B1 (pl) | 2015-05-29 |
Family
ID=36777974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL383722A PL219509B1 (pl) | 2005-02-04 | 2006-02-03 | Zastosowanie kompozycji zawierającej trans-klomifen |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090215906A1 (pl) |
EP (1) | EP1848416A4 (pl) |
JP (1) | JP2008530016A (pl) |
KR (1) | KR20070100811A (pl) |
CN (1) | CN101115477A (pl) |
AU (1) | AU2006210481B2 (pl) |
BR (1) | BRPI0606528A8 (pl) |
CA (1) | CA2595363C (pl) |
MX (1) | MX2007009077A (pl) |
NZ (1) | NZ556499A (pl) |
PL (1) | PL219509B1 (pl) |
RU (1) | RU2404757C2 (pl) |
WO (1) | WO2006084153A2 (pl) |
ZA (1) | ZA200705906B (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2777199A1 (en) | 2001-07-09 | 2003-01-23 | Repros Therapeutics Inc. | Methods and materials for the treatment of testosterone deficiency in men |
US7737185B2 (en) | 2001-07-09 | 2010-06-15 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene |
PL383444A1 (pl) * | 2005-03-22 | 2008-03-17 | Repros Therapeutics Inc. | Sposoby dawkowania trans-klomifenu |
CN102940619A (zh) | 2007-10-16 | 2013-02-27 | 利普生物药剂公司 | 用于治疗代谢综合征的珠氯米芬 |
IT1395957B1 (it) | 2009-05-19 | 2012-11-02 | Pharmaguida S R L | Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile. |
UA113291C2 (xx) | 2011-08-04 | 2017-01-10 | Метаболіти транскломіфену і їх застосування | |
CA2881604C (en) * | 2011-08-09 | 2021-09-14 | Kenneth W. Adams | Use of aromatase inhibitor or estrogen blocker for increasing spermatogenesis or testosterone levels in males |
RU2480256C1 (ru) * | 2012-04-04 | 2013-04-27 | Федеральное государственное бюджетное учреждение "Научный центр проблем здоровья семьи и репродукции человека" Сибирского отделения Российской академии медицинских наук | Способ комплексного лечения нормогонадотропного бесплодия у мужчин |
MX2015005160A (es) | 2012-11-02 | 2015-07-17 | Repros Therapeutics Inc | Trans-clomifeno para uso en terapia de cancer. |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4061733A (en) * | 1976-10-15 | 1977-12-06 | Narayan Vishwanath Gunjikar | Veterinary compositions for inducing estrus in animals and method |
US4729999A (en) * | 1984-10-12 | 1988-03-08 | Bcm Technologies | Antiestrogen therapy for symptoms of estrogen deficiency |
US4820736A (en) * | 1987-03-20 | 1989-04-11 | Yale University | Use of clomiphene to predict fertility in a human female |
JPH04312522A (ja) | 1991-04-08 | 1992-11-04 | Yoshiaki Kawashima | 徐放性錠剤の製造方法 |
US5681585A (en) | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5776923A (en) * | 1993-01-19 | 1998-07-07 | Endorecherche, Inc. | Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
AU2638795A (en) | 1994-06-17 | 1996-01-15 | University Of Nebraska Board Of Regents | In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
DE4435368A1 (de) * | 1994-09-22 | 1996-03-28 | Schering Ag | Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann |
US6221399B1 (en) * | 1995-08-17 | 2001-04-24 | Csir | Method of making controlled release particles of complexed polymers |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
WO1998018610A1 (en) | 1996-10-28 | 1998-05-07 | Lengerich Bernhard H Van | Embedding and encapsulation of controlled release particles |
BR9809064A (pt) * | 1997-04-03 | 2002-01-02 | Guilford Pharm Inc | Polìmeros biodegradáveis de poliéster de tereftalato-polifosfato, composições, artigos e métodos para fazer e usar os mesmos |
US6653297B1 (en) * | 1997-07-03 | 2003-11-25 | Medical College Of Hampton Roads | Control of selective estrogen receptor modulators |
US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
ATE355279T1 (de) * | 1998-08-07 | 2006-03-15 | Novartis Vaccines & Diagnostic | Pyrazole als modulatoren des östrogenrezeptors |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
PE20010404A1 (es) * | 1999-06-11 | 2001-04-09 | Watson Pharmaceuticals Inc | Combinacion de esteroides androgenicos no orales y compuestos estrogenicos y su uso en mujeres |
AU6132700A (en) * | 1999-09-30 | 2001-04-05 | Chienna B.V. | Polymers loaded with bioactive agents |
WO2001052823A2 (en) * | 2000-01-20 | 2001-07-26 | Noven Pharmaceuticals, Inc. | Compositions to effect the release profile in the transdermal administration of drugs |
JP2003534375A (ja) * | 2000-05-26 | 2003-11-18 | フィッチ,ハリー | 選択性抗エストロゲン薬を用いた男性におけるアンドロゲン欠乏症の治療法 |
US7067557B2 (en) * | 2000-05-26 | 2006-06-27 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
WO2002055020A2 (en) * | 2000-12-11 | 2002-07-18 | Testocreme Llc | Topical testosterone formulations and associated methods |
CA2777199A1 (en) | 2001-07-09 | 2003-01-23 | Repros Therapeutics Inc. | Methods and materials for the treatment of testosterone deficiency in men |
US7173064B2 (en) * | 2001-07-09 | 2007-02-06 | Repros Therapeutics Inc. | Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy |
US6645974B2 (en) * | 2001-07-31 | 2003-11-11 | Merck & Co., Inc. | Androgen receptor modulators and methods for use thereof |
US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7105679B2 (en) * | 2001-12-19 | 2006-09-12 | Kanojia Ramesh M | Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
-
2006
- 2006-02-03 EP EP06720243A patent/EP1848416A4/en not_active Withdrawn
- 2006-02-03 AU AU2006210481A patent/AU2006210481B2/en not_active Ceased
- 2006-02-03 MX MX2007009077A patent/MX2007009077A/es active IP Right Grant
- 2006-02-03 CA CA2595363A patent/CA2595363C/en not_active Expired - Fee Related
- 2006-02-03 CN CNA2006800041575A patent/CN101115477A/zh active Pending
- 2006-02-03 KR KR1020077019148A patent/KR20070100811A/ko not_active Application Discontinuation
- 2006-02-03 JP JP2007554250A patent/JP2008530016A/ja active Pending
- 2006-02-03 BR BRPI0606528A patent/BRPI0606528A8/pt not_active IP Right Cessation
- 2006-02-03 PL PL383722A patent/PL219509B1/pl unknown
- 2006-02-03 NZ NZ556499A patent/NZ556499A/en not_active IP Right Cessation
- 2006-02-03 WO PCT/US2006/003882 patent/WO2006084153A2/en active Application Filing
- 2006-02-03 RU RU2007132971/15A patent/RU2404757C2/ru not_active IP Right Cessation
- 2006-02-03 US US11/814,068 patent/US20090215906A1/en not_active Abandoned
-
2007
- 2007-07-18 ZA ZA200705906A patent/ZA200705906B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008530016A (ja) | 2008-08-07 |
WO2006084153A2 (en) | 2006-08-10 |
WO2006084153A3 (en) | 2006-11-02 |
MX2007009077A (es) | 2007-09-13 |
RU2404757C2 (ru) | 2010-11-27 |
EP1848416A4 (en) | 2008-09-24 |
BRPI0606528A2 (pt) | 2009-06-30 |
US20090215906A1 (en) | 2009-08-27 |
NZ556499A (en) | 2011-02-25 |
PL219509B1 (pl) | 2015-05-29 |
RU2007132971A (ru) | 2009-03-10 |
CN101115477A (zh) | 2008-01-30 |
EP1848416A2 (en) | 2007-10-31 |
KR20070100811A (ko) | 2007-10-11 |
ZA200705906B (en) | 2008-04-30 |
AU2006210481A1 (en) | 2006-08-10 |
BRPI0606528A8 (pt) | 2018-03-13 |
CA2595363A1 (en) | 2006-08-10 |
CA2595363C (en) | 2012-03-27 |
AU2006210481B2 (en) | 2011-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20150175T1 (en) | Means and methods for the treatment of tumorous diseases | |
IL186447A0 (en) | Methods for the treatment of substance abuse and dependence | |
IL187444A0 (en) | Tissue treatment device and method | |
EP2008670A4 (en) | STERILIZATION DEVICE AND THIS USING STERILIZATION PROCESS | |
PL383722A1 (pl) | Sposoby i materiały z trans-klomifenem do leczenia bezpłodności u mężczyzn | |
GB0604471D0 (en) | Device and method for the treatment of tumours | |
EP1968505A4 (en) | DEVICES AND METHOD FOR THE TREATMENT OF BONE FRACTURES | |
HK1171972A1 (zh) | 治療疾病的方法和產品 | |
IL187405A0 (en) | Methods and compositions for the treatment of pain | |
EP1933853A4 (en) | TREATMENT OF TISSUE DISTRACTION AND COMPOSITION FOR APPLYING THEREOF | |
GB2445651B (en) | Well treatment products and methods of using them | |
ZA200709443B (en) | Methods for the treatment of substance abuse and dependence | |
ZA200806095B (en) | Means and methods for the treatment of tumorous diseases | |
EP2007790A4 (en) | COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN | |
GB2441094B (en) | Methods for treatment and prevention of infection | |
IL201119A0 (en) | Methods and compositions of derivatives of probucol for the treatment of diabetes | |
GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease | |
IL195888A0 (en) | Materials handling and treatment | |
GB2442881B (en) | Methods for altering gene expression and methods of treatment utilizing same | |
EP1962882A4 (en) | COMPOSITIONS AND METHOD FOR TREATING DIABETES | |
ZA200710476B (en) | Methods and compositions for the treatment of pain | |
ATE439424T1 (de) | Behandlungsprodukt und behandlungsverfahren | |
IL198479A0 (en) | Methods for screening for therapeutic molecules and use of the molecules therefrom | |
GB0517079D0 (en) | Sterilization of enclosed and contaminated areas | |
HK1125634A1 (en) | Pharmaceutical for use in the treatment of ureterolithiasis |